Starlix
- Product NDC
- 0078-0352
- 11-digit product format
- 000780352
- Labeler code
- 0078
- Product ID
- 0078-0352_1c90bc7c-2f9b-4cc4-89c8-1f20ec80a523
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- nateglinide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Novartis Pharmaceuticals Corporation
- Application
- NDA021204
- Marketing category
- NDA
- Marketing start
- 2000-12-04
- Marketing end
- 2022-01-31
- Substance
- NATEGLINIDE
- Active strength
- 120 mg/1
- Pharmacologic classes
- Glinide [EPC],Potassium Channel Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0078-0352-05 | 00078035205 | 100 TABLET in 1 BOTTLE (0078-0352-05) | 100 tablet | 2000-12-04 | 2022-01-31 | No | No | Current |